Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

EuroNanoMed 3/2018-fase II (propuesta completa). Búsqueda de pyme en España, Letonia o Lituania para desarrollar nuevos nano inmunomedicamentos para la enfermedad de Alzheimer

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDGR20180503001
Publicado:
04/05/2018
Caducidad:
14/05/2018
Resumen:
Un consorcio formado por 5 socios del sector de salud pública y académico procedentes de Grecia, Francia, Italia y Turquía está preparando una propuesta completa sobre "Desarrollo de nuevos nano inmunomedicamentos para la enfermedad de Alzheimer", que será presentada a la convocatoria de EuroNanoMed 3/2018. El consorcio busca urgentemente una pyme de biotecnología en España, Letonia o Lituania con experiencia en la producción a gran escala de anticuerpos monoclonales o especializada en producir nanopartículas o liposomas poliméricos. La fecha límite de la convocatoria es el 30 de mayo de 2018 y el plazo para presentar expresiones de interés finaliza el 14 de mayo.

Details

Tittle:
EuroNanoMed 3/2018-phase II (full proposal) - biotech SMEs from Spain, Latvia or Lithuania sought to develop new nano-immunomedicines for Alzheimer´s disease.
Summary:
A consortium of 5 partners from Greece, France, Italy and Turkey coming from academia -Y- the public health sector are preparing a full proposal on "Development of new nano-immunomedicines for Alzheimer´s disease" for the EuroNanoMed 3/2018 call. They are urgently looking for a biotech SME from Spain, Latvia or Lithuania with expertise in the large-scale production of monoclonal antibodies or specialized in the production of polymeric nanoparticles or liposomes.
Description:
A consortium consisting of 5 partners from 4 countries (Greece, France, Italy and Turkey) involving research groups from both academia and the clinical/public health research sector has recently submitted a pre-proposal for the category "Innovation applied research projects", which passed the first evaluation step successfully and is now being submitted at the full proposal submission stage for the EuroNanoMed 3/2018 call.

The proposal aims to advance the development of effective immunotherapy for Alzheimer´s disease (AD) based on the use of nanoparticles. The current consortium members have significant expertise in nanotechnology, molecular biology, immunology and neurobiology, which is necessary for the proposal´s implementation.

They seek one additional partner, an SME, specifically from either Spain, Latvia or Lithuania.

They are urgently looking for:
1. A biotechnology SME capable of designing and implementing the large-scale production of monoclonal antibodies under GMP (Good Manufacturing Practice) conditions
or
2] a pharmaceutical or biotechnology SME specialized in the production of polymeric nanoparticles or liposomes

More information about the research proposal will be provided upon selection.

Call deadline: 30/05/2018
Deadline for Expressions of interest: 14/05/2018

Stage of Development:
Proposal under development

Partner sought

Partner Sought:
The consortium is urgently looking for: 1. A biotechnology SME to undertake the large-scale production - under GMP conditions - of the developed monoclonal antibodies against the two main target neuroantigens Or 2. A pharmaceutical or biotechnology SME which will design and implement a larger (than lab) scale manufacturing process for the nanocarriers (polymeric nanoparticles or liposomes). The selected SME will enter the consortium that will submit a joint full proposal for the EuroNanoMed 3/2018 call with deadline 30/05/18.
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
R-Y-D Institution
Already Engaged in Trans-National Cooperation:
Si

Dissemination

Restrict dissemination to specific countries:
Latvia
Lithuania
Spain

Programme-call

Framwork Programme:
H2020
Evaluation Scheme:
Innovation applied research projects
Coordinator Required:
No
Deadline for Call:
30/05/2018